Username:
Password:
Forgot Password?
Remember me
Decade: 2010-2010 2000-2009 1990-1999 1980-1989 1970-1979
Year: 2010
Issues: Vol. 106 No. 6 September 15, 2010 p.757-910 Vol. 106 No. 5 September 1, 2010 p.605-756 Vol. 106 No. 4 August 15, 2010 p.451-604 Vol. 106 No. 3 August 1, 2010 p.297-450 Vol. 106 No. 2 July 15, 2010 p.143-296 Vol. 106 No. 1 July 1, 2010 p.1-142 Vol. 105 No. 12 June 15, 2010 p.1651-1846 Vol. 105 No. 11 June 1, 2010 p.1507-1650 Vol. 105 No. 10 May 15, 2010 p.1361-1506 Vol. 105 No. 9 May 1, 2010 p.1207-1360 Vol. 105 No. 9 April 28, 2010 p.1A-124A-Supplement Vol. 105 No. 8 April 15, 2010 p.1047-1206 Vol. 105 No. 7 April 1, 2010 p.905-1046 Vol. 105 No. 6 March 15, 2010 p.761-904 Vol. 105 No. 5 March 1, 2010 p.581-760 Vol. 105 No. 4 February 15, 2010 p.429-580 Vol. 105 No. 3 February 1, 2010 p.283-428 Vol. 105 No. 2 January 15, 2010 p.139-282 Vol. 105 No. 1 January 4, 2010 p.1A-48A-Supplement Vol. 105 No. 1 January 1, 2010 p.1-138
The Cardiovascular Continuum in the 21st Century: Renin-Angiotensin System Blockade
16 May 2007 - 16 May 2007
Edited by Jeffrey L. Probstfield MD, Michael A. Weber MD
This supplement is supported by Boehringer Ingelheim GmbH
Search Within This Issue
8 Articles:
The authors who contributed to this publication have disclosed the following industry relationships:
Papers in this supplement explore the pathology of cardiovascular risk, the identification of high-risk patients, and the role of RAS blockade in their treatment. Longitudinal and epidemiologic studie...
Current epidemiologic predictions show that the world is heading for a vascular tsunami of pandemic proportions. The number of people at high risk from cardiovascular disease is increasing; recent coh...
The renin–angiotensin system (RAS) plays key roles throughout the cardiovascular continuum, and blockade of this system—either through angiotensin-converting enzyme (ACE) inhibition or through angiote...
Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) are recognized to reduce cardiovascular and renal morbidity and mortality, which is primarily attributed to their...
The renin–angiotensin–aldosterone system (RAAS) plays an important role in the pathogenesis of a variety of clinical conditions, including atherosclerosis, hypertension, left ventricular hypertrophy, ...
Increasing attention is being devoted to the use of combination therapy with angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) in order to achieve maximal blockad...
